Privia Health Group, Inc. (PRVA): who owns it and who trades it
As of Nov 16, 2026, PRVA insiders reported 40 open-market sales worth $22.2M and no purchases in the last 12 months, with 87% of the sale value made under pre-set 10b5-1 plans. The largest seller was Matthew Shawn Morris (Director), with $11.9M. 4 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Privia Health Group
From the latest filingsOverall: about as much buying as selling. Insiders mostly sold. Famous investors mostly bought. Funds was close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns PRVA
301 funds and institutions reported PRVA shares worth $3.3B at the end of Q2 2026. Some shares are counted by more than one filer, or lent out and counted twice, so the total can pass 100%. The largest holder is BlackRock, Inc. with 17.0%.
Funds and institutions (13F) about 100%Everyone else 0%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| BlackRock, Inc. | 21.40M | 16.98% | $551M | +12% |
| FMR LLC (Fidelity) | 12.85M | 10.20% | $331M | -2% |
| Durable Capital Partners LP | 11.64M | 9.23% | $299M | -4% |
| Vanguard Portfolio Management LLC | 6.57M | 5.22% | $169M | +5% |
| Rubicon Founders LLC | 5.97M | 4.74% | $154M | +0% |
| Vanguard Capital Management LLC | 5.16M | 4.09% | $133M | +3% |
| State Street Corp | 4.91M | 3.89% | $126M | +9% |
| Van Berkom & Associates Inc. | 3.71M | 2.95% | $95.5M | -54% |
| Geode Capital Management, LLC | 3.13M | 2.48% | $80.6M | +8% |
| Riverbridge Partners LLC | 3.00M | 2.38% | $77.2M | -23% |
| Bank of New York Mellon Corp | 2.89M | 2.30% | $74.4M | -2% |
| California State Teachers Retirement System | 2.73M | 2.17% | $106M | +2771% |
| Principal Financial Group Inc | 2.59M | 2.05% | $66.6M | -5% |
| Dimensional Fund Advisors LP | 2.55M | 2.03% | $65.7M | +6% |
| Wellington Management Group LLP | 2.13M | 1.69% | $54.8M | +851% |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 1.95M | 1.55% | $50.1M | -5% |
| BlackBarn Capital Partners LP | 1.58M | 1.26% | $40.8M | No change |
| Nuveen, LLC | 1.47M | 1.16% | $37.7M | +55% |
| Bank of America Corp | 1.43M | 1.14% | $36.8M | +14% |
| Charles Schwab Investment Management Inc | 1.37M | 1.09% | $35.4M | +4% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, PRVA insiders reported $0 of open-market purchases and $22.2M of sales. 87% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jul 9, 2026 | David Mountcastle | CFO | Sale plan | 21,275 | $27.67 | $589K | Form 4 |
| Jul 7, 2026 | David Mountcastle | CFO | Sale plan | 600 | $27.57 | $16.5K | Form 4 |
| Jul 6, 2026 | Matthew Shawn Morris | Director | Sale plan | 53,722 | $27.24 | $1.5M | Form 4 |
| Jul 2, 2026 | Matthew Shawn Morris | Director | Sale plan | 59,037 | $27.33 | $1.6M | Form 4 |
| Jul 2, 2026 | David Mountcastle | CFO | Sale plan | 24,734 | $27.50 | $680K | Form 4 |
| Jul 1, 2026 | Matthew Shawn Morris | Director | Sale plan | 37,041 | $26.93 | $998K | Form 4 |
| Jul 1, 2026 | Matthew Shawn Morris | Director | Sale plan | 45,634 | $26.52 | $1.2M | Form 4 |
| Jun 30, 2026 | Matthew Shawn Morris | Director | Sale plan | 52,823 | $25.72 | $1.4M | Form 4 |
| Jun 29, 2026 | Matthew Shawn Morris | Director | Sale plan | 63,212 | $25.33 | $1.6M | Form 4 |
| Jun 26, 2026 | Matthew Shawn Morris | Director | Sale plan | 88,110 | $25.33 | $2.2M | Form 4 |
| Jun 26, 2026 | David Mountcastle | CFO | Sale plan | 17,196 | $25.18 | $433K | Form 4 |
| May 12, 2026 | Parth Mehrotra | CEO | Sale plan | 15,647 | $22.64 | $354K | Form 4 |
| May 11, 2026 | Parth Mehrotra | CEO | Sale plan | 105,439 | $22.55 | $2.4M | Form 4 |
| May 11, 2026 | David Mountcastle | CFO | Sale | 3,385 | $22.60 | $76.5K | Form 4 |
| May 4, 2026 | David Mountcastle | CFO | Sale plan | 1,206 | $25.00 | $30.1K | Form 4 |
| May 4, 2026 | Matthew Shawn Morris | Director | Sale plan | 1,017 | $24.96 | $25.4K | Form 4 |
| May 1, 2026 | David Mountcastle | CFO | Sale plan | 7,179 | $25.03 | $180K | Form 4 |
| May 1, 2026 | Matthew Shawn Morris | Director | Sale plan | 17,096 | $24.99 | $427K | Form 4 |
| Apr 2, 2026 | David Mountcastle | CFO | Sale | 5,566 | $20.85 | $116K | Form 4 |
| Mar 16, 2026 | David Mountcastle | CFO | Sale | 6,391 | $22.11 | $141K | Form 4 |
| Mar 16, 2026 | Parth Mehrotra | CEO | Sale | 26,509 | $22.11 | $586K | Form 4 |
| Mar 13, 2026 | David Mountcastle | CFO | Sale | 6,565 | $21.52 | $141K | Form 4 |
| Mar 13, 2026 | Parth Mehrotra | CEO | Sale | 27,229 | $21.52 | $586K | Form 4 |
| Mar 12, 2026 | David Mountcastle | CFO | Sale | 6,453 | $21.90 | $141K | Form 4 |
| Mar 12, 2026 | Parth Mehrotra | CEO | Sale | 26,763 | $21.90 | $586K | Form 4 |
| Mar 10, 2026 | Parth Mehrotra | CEO | Sale plan | 21,097 | $22.71 | $479K | Form 4 |
| Mar 9, 2026 | Parth Mehrotra | CEO | Sale plan | 21,915 | $22.84 | $501K | Form 4 |
| Mar 9, 2026 | Parth Mehrotra | CEO | Sale plan | 18,865 | $22.84 | $431K | Form 4 |
| Mar 9, 2026 | Parth Mehrotra | CEO | Sale plan | 1,219 | $23.37 | $28.5K | Form 4 |
| Mar 9, 2026 | Edward C Fargis | Vice president | Sale | 4,949 | $22.84 | $113K | Form 4 |
| Mar 9, 2026 | David Mountcastle | CFO | Sale | 5,829 | $22.84 | $133K | Form 4 |
| Mar 6, 2026 | Parth Mehrotra | CEO | Sale plan | 21,440 | $23.15 | $496K | Form 4 |
| Mar 6, 2026 | Edward C Fargis | Vice president | Sale | 4,394 | $23.15 | $102K | Form 4 |
| Mar 6, 2026 | David Mountcastle | CFO | Sale | 5,177 | $23.15 | $120K | Form 4 |
| Feb 27, 2026 | Matthew Shawn Morris | Director | Sale plan | 16,550 | $25.00 | $414K | Form 4 |
| Feb 27, 2026 | David Mountcastle | CFO | Sale plan | 7,697 | $25.05 | $193K | Form 4 |
| Feb 26, 2026 | Matthew Shawn Morris | Director | Sale plan | 7,788 | $24.99 | $195K | Form 4 |
| Feb 26, 2026 | David Mountcastle | CFO | Sale plan | 5,361 | $25.00 | $134K | Form 4 |
| Dec 12, 2025 | Matthew Shawn Morris | Director | Sale plan | 13,647 | $25.01 | $341K | Form 4 |
| Dec 12, 2025 | David Mountcastle | CFO | Sale plan | 23,887 | $25.03 | $598K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Matthew Shawn Morris | Director | – | $11.9M | Jul 6, 2026 |
| Parth Mehrotra | Chief Executive Officer, Director | – | $6.4M | May 12, 2026 |
| David Mountcastle | EVP & Chief Financial Officer | – | $3.7M | Jul 9, 2026 |
| Edward C Fargis | EVP & General Counsel | – | $215K | Mar 9, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
PRVA short interest
Low short interest. 3.1% of PRVA shares are sold short: about 1 share in 33. Over the last 12 reports the number of shares short went up 15%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 3.90M PRVA shares were sold short, 3.1% of the shares outstanding, down 22.2% from the report before. At the average daily volume of 857,040 shares, buying them all back would take about 4.5 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 3.90M | 3.05% | -22% | 857,040 | 4.5 |
| Oct 15, 2026 | 5.01M | 3.92% | -14% | 1.44M | 3.5 |
| Sep 30, 2026 | 5.81M | 4.55% | +19% | 1.35M | 4.3 |
| Sep 15, 2026 | 4.90M | 3.84% | -10% | 1.24M | 4.0 |
| Aug 31, 2026 | 5.45M | 4.27% | +3% | 867,248 | 6.3 |
| Aug 14, 2026 | 5.29M | 4.14% | +38% | 1.55M | 3.4 |
| Jul 31, 2026 | 3.84M | 3.00% | +4% | 1.14M | 3.4 |
| Jul 15, 2026 | 3.69M | 2.93% | -1% | 1.11M | 3.3 |
| Jun 30, 2026 | 3.72M | 2.95% | +24% | 1.39M | 2.7 |
| Jun 15, 2026 | 2.99M | 2.38% | -10% | 1.02M | 2.9 |
| May 29, 2026 | 3.33M | 2.64% | -2% | 748,482 | 4.4 |
| May 15, 2026 | 3.39M | 2.69% | +6% | 1.30M | 2.6 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Privia Health Group company events
Privia Health Group filed 8 reports on Form 8-K in the last 12 months, 2 of them about an important change (leadership). The latest was on Nov 5, 2026.
- Nov 5, 2026ResultsReleased financial results. Filing
- Aug 18, 2026LeadershipDeparture of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers. Filing
- Aug 6, 2026ResultsReleased financial results. Filing
- Jul 7, 2026LeadershipDeparture of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers. Filing
- May 22, 2026VoteReported shareholder vote results. Filing
- May 7, 2026ResultsReleased financial results. Filing
- Feb 26, 2026ResultsReleased financial results. Filing
- Dec 8, 2025AnnouncementPreviously, on September 23, 2025, Privia Health Group, Inc. announced the entry into a definitive agreement to acquire an Accountable Care Organization business from Evolent Health, Inc. The transaction closed on December 5, 2025. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Privia Health Group financials
Famous investors that hold PRVA
4 of the 50 well-known investors we track reported holding PRVA in their latest 13F filing. The largest position is Steve Cohen's, worth $40.2M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Steve Cohen · Point72 Asset Management | Q3 2026 | 2.04M | $40.2M | 0.1% | New |
| Jim Simons · Renaissance Technologies | Q3 2026 | 613,300 | $12.1M | 0.0% | -3% |
| Ken Griffin · Citadel Advisors | Q3 2026 | 563,729 | $11.1M | 0.0% | +1054% |
| Israel Englander · Millennium Management | Q3 2026 | 348,314 | $6.9M | 0.0% | +30% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 4 filings named PRVA in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Oct 30, 2026 | Vanguard Capital Management | 13G | 5.1% |
| Oct 30, 2026 | Vanguard Capital Management | 13G | 5.1% |
| Oct 7, 2026 | FMR LLC | 13G/A | 5.0% |
| Oct 7, 2026 | FMR LLC | 13G/A | 5.0% |
Questions about Privia Health Group, Inc. (PRVA) stock
Who owns the most PRVA stock?
The largest reported owner of Privia Health Group, Inc. (PRVA) is BlackRock, Inc., with 17.0% of the company. In total, 301 funds and institutions reported holding PRVA at the end of Q2 2026, together about 100% of the shares. See the largest owners.
Are PRVA insiders buying or selling?
In the last 12 months, PRVA insiders reported no open-market purchases and 40 sales worth $22.2M. The latest trade was on Jul 9, 2026. See every trade.
What is the short interest in PRVA?
As of Oct 30, 2026, 3.90M PRVA shares were sold short, 3.1% of the shares outstanding, down 22.2% from the report before. At the average daily volume of 857,040 shares, buying them all back would take about 4.5 trading days (days to cover). See the history.
Which famous investors hold PRVA?
4 of the 50 well-known investors we track reported PRVA in their latest 13F filing, including Steve Cohen, Jim Simons, Ken Griffin. The largest position is worth $40.2M. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.